ACT Capital Management
WAYNE, PAfiles as ACT CAPITAL MANAGEMENT, LLC
$153m in 62 US stocks at the end of 30 June 2026. The top 10 are 66.0% of the money. It changed about 25.5% of the portfolio this quarter.
Value
$153m
Stocks
62
Top 10 share
66.0%
Turnover
25.5%
What changed this quarter
New
Bought for the first time this quarter.
- TeslaTSLA3.0% of the fund
- AST SpaceMobileASTS2.5% of the fund
- Palvella TherapeuticsPVLA2.2% of the fund
- Nebius GroupNBIS1.2% of the fund
- AmbarellaAMBA0.9% of the fund
- Cerebras SystemsCBRS0.8% of the fund
- Definium TherapeuticsDFTX0.8% of the fund
- NokiaNOK0.7% of the fund
- CamecoCCJ0.6% of the fund
- Mineralys TherapeuticsMLYS0.5% of the fund
- Palantir TechnologiesPLTR0.4% of the fund
- ON SemiconductorON0.4% of the fund
- Keel InfrastructureKEEL0.3% of the fund
- Corvus PharmaceuticalsCRVS0.3% of the fund
- AXTAXTI0.2% of the fund
- InfleqtionINFQ0.2% of the fund
- Adlai NortyeANL0.2% of the fund
- Capstone Energy PlusCEPL0.2% of the fund
- VivoPowerVIVO0.1% of the fund
- Space Exploration TechnologiesSPCX<0.1% of the fund
Added
Bought more of a stock they already held.
- Abivax SAABVX8.4% of the fund+37%
- ExxonMobil HoldingsXOM7.0% of the fund+12%
- Arrowhead PharmaceuticalsARWR5.9% of the fund+33%
- Nektar TherapeuticsNKTR4.1% of the fund+26%
- Nuvation BioNUVB1.9% of the fund+79%
- Xenon PharmaceuticalsXENE1.9% of the fund+43%
- Bloom EnergyBE1.5% of the fund+67%
- Kura OncologyKURA0.6% of the fund+20%
- Monte Rosa TherapeuticsGLUE0.6% of the fund+56%
- RegenxbioRGNX0.5% of the fund+21%
- Palisade BIOPALI0.4% of the fund+19%
- COMPASS PathwaysCMPS0.3% of the fund+94%
- Kyverna TherapeuticsKYTX0.2% of the fund+33%
- Ryerson HoldingRYZ0.2% of the fund+4%
Cut
Sold some of their stake.
- Krystal BiotechKRYS10.9% of the fund-26%
- CelcuityCELC4.2% of the fund-32%
- CytokineticsCYTK2.6% of the fund-26%
- Amazon.comAMZN2.0% of the fund-61%
- Freeport-McMoRanFCX1.3% of the fund-16%
- AlumisALMS0.9% of the fund-70%
- Applied OptoelectronicsAAOI0.6% of the fund-77%
- MBX BiosciencesMBX0.3% of the fund-11%
- Scholar Rock HoldingSRRK0.2% of the fund-44%
- UiPathPATH0.2% of the fund-40%
- GeneDx HoldingsWGS0.2% of the fund-50%
- Micron TechnologyMU0.2% of the fund-87%
Sold out
Sold their entire stake.
- Staar SurgicalSTAA-100%
- SentinelOneS-100%
- Lumentum HoldingsLITE-100%
- Circle Internet GroupCRCL-100%
- NvidiaNVDA-100%
- Replimune GroupREPL-100%
- Olema PharmaceuticalsOLMA-100%
- IncyteINCY-100%
- Capricor TherapeuticsCAPR-100%
- Vishay Precision GroupVPG-100%
- Esperion Therapeutics INC NE-100%
- Amylyx PharmaceuticalsAMLX-100%
- LantronixLTRX-100%
- Hims & Hers HealthHIMS-100%
Holdings
- Abivax SAABVX
- Share
- 8.4%
- Value
- $13m
- Shares
- 97,000
+37%
- Energy Transfer L PET
- Share
- 1.7%
- Value
- $3m
- Shares
- 133,100
Held
- Cerebras SystemsCBRS
- Share
- 0.8%
- Value
- $1m
- Shares
- 5,600
New
- NokiaNOK
- Share
- 0.7%
- Value
- $1m
- Shares
- 82,000
New
- CamecoCCJ
- Share
- 0.6%
- Value
- $855,624
- Shares
- 8,400
New
- Grayscale Bitcoin Trust ETFGBTC
- Share
- 0.5%
- Value
- $701,008
- Shares
- 15,400
Held
- Adlai NortyeANL
- Share
- 0.2%
- Value
- $310,500
- Shares
- 27,000
New
- Space Exploration TechnologiesSPCX
- Share
- <0.1%
- Value
- $136,688
- Shares
- 800
New
- Lightspeed CommerceLSPD
- Share
- <0.1%
- Value
- $131,125
- Shares
- 12,500
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Krystal BiotechKRYS | 10.9% | $17m | 45,000 | -26% |
| TG TherapeuticsTGTX | 9.0% | $14m | 251,025 | Held |
| Abivax SAABVX | 8.4% | $13m | 97,000 | +37% |
| ChevronCVX | 8.1% | $12m | 75,000 | Held |
| ExxonMobil HoldingsXOM | 7.0% | $11m | 78,500 | +12% |
| Arrowhead PharmaceuticalsARWR | 5.9% | $9m | 110,100 | +33% |
| Viking TherapeuticsVKTX | 5.3% | $8m | 209,300 | Held |
| CelcuityCELC | 4.2% | $7m | 62,150 | -32% |
| Nektar TherapeuticsNKTR | 4.1% | $6m | 89,300 | +26% |
| TeslaTSLA | 3.0% | $5m | 10,800 | New |
| CytokineticsCYTK | 2.6% | $4m | 47,500 | -26% |
| AST SpaceMobileASTS | 2.5% | $4m | 43,500 | New |
| Palvella TherapeuticsPVLA | 2.2% | $3m | 22,500 | New |
| Amazon.comAMZN | 2.0% | $3m | 12,900 | -61% |
| Nuvation BioNUVB | 1.9% | $3m | 520,000 | +79% |
| Xenon PharmaceuticalsXENE | 1.9% | $3m | 48,000 | +43% |
| Energy Transfer L PET | 1.7% | $3m | 133,100 | Held |
| Bloom EnergyBE | 1.5% | $2m | 7,500 | +67% |
| Freeport-McMoRanFCX | 1.3% | $2m | 32,500 | -16% |
| Nebius GroupNBIS | 1.2% | $2m | 6,800 | New |
| AlumisALMS | 0.9% | $1m | 51,600 | -70% |
| AmbarellaAMBA | 0.9% | $1m | 16,000 | New |
| Cerebras SystemsCBRS | 0.8% | $1m | 5,600 | New |
| Definium TherapeuticsDFTX | 0.8% | $1m | 25,000 | New |
| NokiaNOK | 0.7% | $1m | 82,000 | New |
| Kura OncologyKURA | 0.6% | $975,233 | 88,900 | +20% |
| Praxis Precision MedicinesPRAX | 0.6% | $903,933 | 2,700 | Held |
| Applied OptoelectronicsAAOI | 0.6% | $888,960 | 6,000 | -77% |
| CamecoCCJ | 0.6% | $855,624 | 8,400 | New |
| Monte Rosa TherapeuticsGLUE | 0.6% | $847,000 | 35,000 | +56% |
| RegenxbioRGNX | 0.5% | $808,650 | 67,500 | +21% |
| Mineralys TherapeuticsMLYS | 0.5% | $758,138 | 28,100 | New |
| Grayscale Bitcoin Trust ETFGBTC | 0.5% | $701,008 | 15,400 | Held |
| Vir BiotechnologyVIR | 0.4% | $655,217 | 64,300 | Held |
| Palisade BIOPALI | 0.4% | $642,675 | 307,500 | +19% |
| Palantir TechnologiesPLTR | 0.4% | $641,685 | 5,500 | New |
| ON SemiconductorON | 0.4% | $567,240 | 6,000 | New |
| Warrior MET CoalHCC | 0.3% | $486,960 | 6,000 | Held |
| Crescent EnergyCRGY | 0.3% | $441,900 | 45,000 | Held |
| MBX BiosciencesMBX | 0.3% | $441,600 | 8,000 | -11% |
| Keel InfrastructureKEEL | 0.3% | $427,630 | 74,500 | New |
| COMPASS PathwaysCMPS | 0.3% | $424,500 | 30,000 | +94% |
| Corvus PharmaceuticalsCRVS | 0.3% | $403,380 | 27,000 | New |
| Alpha CognitionACOG | 0.2% | $371,830 | 51,500 | Held |
| Kyverna TherapeuticsKYTX | 0.2% | $356,400 | 40,000 | +33% |
| AXTAXTI | 0.2% | $353,192 | 4,900 | New |
| InfleqtionINFQ | 0.2% | $333,000 | 25,000 | New |
| Scholar Rock HoldingSRRK | 0.2% | $330,000 | 6,000 | -44% |
| UiPathPATH | 0.2% | $326,100 | 30,000 | -40% |
| Adlai NortyeANL | 0.2% | $310,500 | 27,000 | New |
| OndasONDS | 0.2% | $309,000 | 37,500 | Held |
| ARKO PetroleumAPC | 0.2% | $282,750 | 15,000 | Held |
| Ryerson HoldingRYZ | 0.2% | $275,632 | 11,200 | +4% |
| GeneDx HoldingsWGS | 0.2% | $274,600 | 4,000 | -50% |
| Capstone Energy PlusCEPL | 0.2% | $253,000 | 27,500 | New |
| Micron TechnologyMU | 0.2% | $230,858 | 200 | -87% |
| Terra Innovatum GlobalNKLR | 0.1% | $221,400 | 45,000 | Held |
| VivoPowerVIVO | 0.1% | $219,725 | 42,500 | New |
| Space Exploration TechnologiesSPCX | <0.1% | $136,688 | 800 | New |
| Lightspeed CommerceLSPD | <0.1% | $131,125 | 12,500 | Held |
| StratasysSSYS | <0.1% | $85,600 | 10,000 | Held |
| PDS BiotechnologyPDSB | <0.1% | $26,433 | 30,000 | Held |
Over time and by industry
Value over time
Dec '25
Jun '26
Value is up 23.8% since 31 December 2025.
Where the money is
Health care55.3%
Energy15.7%
Technology5.5%
Retail & consumer5.0%
Media & telecom2.5%
Industrials2.2%
Materials1.9%
Financial services0.3%
Utilities0.1%
Other11.5%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.